All In MedTech

FDA Clearance Tracker · P000053-S105

AMS 800 Artificial Urinary Sphincter with and without InhibiZone Treatment

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 30, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 30, 2019

Approved

Time to decision

220 days

Received May 24, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000053-S105
Device name
AMS 800 Artificial Urinary Sphincter with and without InhibiZone Treatment
Applicant location
Marlboro, MA
Received
May 24, 2019
Decided
Dec 30, 2019
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P000053

Device type

Device class
Class III
Regulation
21 CFR 876.5280

Every decision under product code EZY

FDA's approval statement

As written in FDA's record.

Approval for a Liquid Injection Molding process change and silicone material change.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.